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A 73-year-old woman without a cardiovascular
history was admitted with chest discomfort, dizziness,
and nausea after an emotional meeting with the staff of a
nursing home. She experienced the same complaints
some years before when her father died.
On admission the patient was in cardiogenic shock.
Auscultation of the heart revealed a grade 3/6 systolic
murmur radiating to the left axilla. The electrocardio-
graphy (ECG) showed an acute anterior wall infarction
(Figure 1). Acute coronary angiography was performed
but no signiﬁcant coronary artery disease was found.
Left ventricular (LV) angiography showed severe mitral
regurgitation and apical ballooning (Figure 2). An
intraventricular gradient of 100 mmHg was measured.
Echocardiography showed apical akinesia and basal
hyperkinesia resulting in severe mitral regurgitation due
to systolic anterior movement of the anterior mitral
valve leaﬂet. Troponin T (1.73 ng/L) and CK-MB
(22 lg/L) were slightly increased. Based on these ﬁnd-
ings, the diagnosis of a takotsubo cardiomyopathy (TC)
was made. Shortly after treatment with intravenous
inotropics, and ACE inhibition the patient became
hemodynamically stable and metoprolol was added.
Cardiac MRI did not show late contrast enhance-
ment which excludes myocardial ﬁbrosis and myocardial




a radiolabelled noradrenalin analog) scintigraphy, per-
formed 4 days after admission, showed diffuse reduced
myocardial uptake and increased washout of
123I-MIBG
which reﬂects impaired sympathetic neuronal function
and increased sympathetic activity, respectively (Fig-
ure 3A). Cardiac ultrasound was repeated at 3 and
7 months and showed no mitral regurgitation and a
normalized LV function. However, cardiac sympathetic
neuronal function and activity remained abnormal as was
shown by
123I-MIBG scintigraphy at 3 and 7 months
(Figure 3B and C, respectively).
The diagnosis of a stress-induced cardiomyopathy,
apical ballooning syndrome or TC was based on the
presence of the typical symptoms and signs of an ante-
rior wall infarction after a highly stressful moment
(a lifetime crisis), combined with normal coronary
angiography, LV apical ballooning, no signs of late
contrast enhancement on MRI scanning, and rapid
recovery of LV function.
1
The name Takotsubo is related to the morphology
of the left ventricle, which shows resemblance to a
Japanese round-bottomed narrow-necked ﬁshing pot
used for trapping octopus. Postmenopausal women seem
to be most at risk for developing this syndrome, espe-
cially after an episode of acute emotional stress. In a
systematic review, women accounted for 82-100% of
patients with an average age of 62-75 years, although
cases have been described in individuals aged
10-91 years.
2 Formal diagnostic criteria have yet to be
established. Bybee et al have suggested diagnostic cri-
teria for TC, requiring the following: (1) transient LV
wall motion abnormalities involving the apical and/or
midventricular myocardial segments with wall motion
abnormalities extending beyond a single epicardial
coronary distribution; (2) absence of obstructive epi-
cardial CAD or angiographic evidence of acute plaque
rupture that could be responsible for the observed wall
motion abnormality; and (3) new ECG abnormalities
such as transient ST-segment elevation and/or diffuse
T-wave inversions or Troponin T elevation.
2-4
Although the exact pathophysiology of TC is
unknown, it has been suggested that catecholamine-
mediated cardiac toxicity is related to the pathophysio-
logical basis of TC. In these patients, increased
myocardial sympathetic activity is caused by increased
presynaptic release and reduced re-uptake of noradren-
alin. This leads to down regulation and desensitization
of the postsynaptic cardiac b-adrenoreceptors, leading to
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321a further decline of the LV function.
5 The changes in the
presynaptic myocardial sympathetic activity can be
assessed with the radio-labeled noradrenalin analog
123I-MIBG.
6 However, it has been shown that some
b-adrenoreceptor-blockers may inﬂuence myocardial
123I-MIBG uptake. This has also been suggested for
ACE-inhibitors. This may explain in part the initial
scintigraphic ﬁndings. However, in the case report of
Moreo et al
123I-MIBG myocardial uptake increased,
after a 2-month treatment with carvedilol.
6 Moreover, in
patients with heart failure b-adrenoreceptor-blockers
and ACE inhibitors are associated with an increase in
123I-MIBG uptake and reduced washout.
7,8 In our patient
ACE inhibition was discontinued after the acute phase
and the b-adrenoreceptor-blocker was continued.
Another possible confounding factor of persisting
abnormal
123I-MIBG scintigraphic ﬁndings is denerva-
tion due to a previous myocardial infarction. However,
MRI showed no signs of a previous myocardial infarc-
tion. Taken together it is likely that the scintigraphic
images, at presentation and during follow-up, reﬂect true
persisting increased myocardial sympathetic activity.
Another possible pathophysiological mechanism for
the development of TC might be related to stress-induced
coronary epicardial spasm or endothelial dysfunction
resulting in myocardial stunning. In a recent study, Sato
et al evaluated coronary artery endothelial dysfunction in
35 patients with TC.
9 In 54% of patients with TC, diffuse
coronary vasoconstriction occurred after intracoronary
acetylcholineprovocation.Intheacutephase,myocardial
perfusion and myocardial fatty acid metabolism scintig-
raphy (
123I-BMIPP) were impaired. During follow-up
myocardial perfusion and myocardial fatty acid metabo-
lismimprovedtonormalinassociationwithimprovement
of LV function. Myocardial stunning due to stress-
induced coronary epicardial spasm or endothelial dys-
function might therefore be a likely explanation for TC.
Figure 1. ECG at admission suggestive for an acute anterior
wall infarction: sinus-rhythm with 58 beats per minute, 1st
degree AV block, ST segment elevation in leads V1-V4, and
pathological Q waves in V2 and V3.
Figure 2. Left ventricular (LV) angiography showing severe
mitral regurgitation and apical ballooning.
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123I-MIBG scintigraphy: images on the left were made 15 min postinjection (p.i.) of
123I-MIBG (early) and the images on the right were made 4 h p.i. (late). Upper left panel shows the
regions of interest over the myocardium and mediastinum for the calculation of the semiquan-
titative parameters of
123I-MIBG myocardial uptake and washout.
123I-MIBG images 4 days after
hospital admission, show severely reduced myocardial uptake (A). Semiquantitative analysis of the
myocardial uptake conﬁrmed the visual interpretation (early heart/mediastinal (H/M) ratio: 1.54,
late H/M: 1.26 and myocardial washout of
123I-MIBG: 18%). Three (B) and seven months (C) after
hospital admission
123I-MIBG myocardial uptake and washout remained abnormal. The
semiquantitative parameters remained abnormal after 3 months (early H/M: 1.78, late H/M: 1.33,
and myocardial washout of
123I-MIBG: 25%) and after 7 months (early H/M: 1.66, late H/M: 1.13,
and myocardial washout of
123I-MIBG: 32%). Due to the diffuse reduced myocardial
123I-MIBG
uptake SPECT images could not reliably be reconstructed.
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123I-MIBG and takotsubo cardiomyopathyAssessment of myocardial perfusion with SPECT
and PET tracers and assessment of glucose metabolism
with
18F-FDG have been used to evaluate TC
patients.
10-15 Typically in the early/acute phase of TC
myocardial perfusion can be (regionally, i.e., apex)
disturbed and shows an impaired (regional, i.e., apex)
coronary ﬂow reserve (CFR) and a more pronounced
impairment of (regional, i.e., apex) myocardial glucose
metabolism. In general, the regional reduction of per-
fusion and impairment of glucose metabolism have the
tendency to resolve completely 3 months after the early/
acute phase.
In our patient, myocardial sympathetic activity was
increased in the early phase of TC. Although LV function
was completely normalized, increased myocardial sym-
pathetic activity persisted. Normalization of myocardial
123I-MIBG uptake has been described in several case
reports.
6,16 This is the ﬁrst report showing persisting
sympathetic dysfunction in a patient with TC after com-
pletenormalizationoftheLVfunctionandnosignsoflate
enhancement on MRI. The recurrence of TC is rare and is
estimated at 2.9% per year and the overall cardiovascular
survival is not different from age- and gender-matched
controls.
17 Echocardiographic follow-up of TC patients
has never been performed in a consistent way. This may
implicatethattherecurrencerateofTCisunderestimated.
In the present case, the patient experienced the same
symptoms after an emotional event several years earlier
which may have been an earlier episode of TC.
Predictors of TC recurrence are not known. As
TC is associated with a hyperadrenergic state, the per-
sisting increased myocardial sympathetic activity may
have prognostic implications.
18 Therefore, myocardial
123I-MIBG scintigraphy may identify patients at risk for
the recurrence of TC. These ﬁndings may warrant
extensive pharmacological therapy and follow-up in TC
patients. Theoretically, recurrence rates may be lower in
those who are maintained on adrenergic blockade
assuming that catecholamines play a central role in the
pathogenesis of the syndrome.
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